Analyst Upgrades for 11/19/2009... AmerisourceBergen (NYSE:ABC) initiated as Buy at UBS... AvalonBay Communities (NYSE:AVB) upgraded to Outperform at RBC... Cardinal Health (NYSE:CAH) initiated as Buy at UBS... Chicos (NYSE:CHS) reiterated Outperform, raised price target to $18 from $15, at FBR... CLARCOR (NYSE:CLC) upgraded to Buy, $40 target, at BB&T... CNA Financial (NYSE:CAN) upgraded to Buy, $27 target, at BofA/Merrill... CVS Caremark (NYSE:CVS) initiated as Buy at UBS... Endurance Specialty (NYSE:ENH) upgraded to Buy at Stifel Nicolaus... ENSCO International (NYSE:ESV) upgraded to Buy at MKM Partners... Express Scripts (NASDAQ:ESRX) initiated as Buy at UBS... Infinity Property (NASDAQ:IPCC) upgraded to Neutral from Underperform, $45 target, at BofA/Merrill... Lear (NYSE:LEA) initiated as Outperform at Credit Suisse... McKesson (NYSE:MCK) initiated as Buy at UBS... Medco Health (NYSE:MHS) initiated as Buy at UBS... Momenta Pharma (NASDAQ:MNTA) upgraded to Outperform from Perform, $15 target, at Oppenheimer... Myriad Pharmaceuticals (NASDAQ:MYRX) upgraded to Neutral from Underweight, $5 target, at Piper Jaffray... National Interstate (NASDAQ:NATL) upgraded to Neutral, $19 target, at BofA/Merrill... Saint Mary Land (NYSE:SM) upgraded to Buy, $42 target, at KeyBanc... Selective Insurance (NASDAQ:SIGI) upgraded to Buy, $18 target, at BofA/Merrill... Solarfun Power (NASDAQ:SOLF) upgraded to Outperform from Perform, $10 target, at Oppenheimer... Symmetry Medical (NYSE:SMA) upgraded to Market Perform from Underperform, $7-9 target, at Wells Fargo... Target (NYSE:TGT) upgraded to Market Perform, $54 target, at BMO Capital... XL Capital (NYSE:XL) upgraded to Outperform from Market Perform at Bernstein... Whole Foods (NASDAQ:WMFI) upgraded to Outperform at BMO Capital...